Nov 29, 2021 / 03:00PM GMT
Operator
Good day, everyone, and welcome to the Meet GSK Management: Getting Ahead of HIV Conference, hosted by David Redfern, Chairman of ViiV Healthcare and Chief Strategy Officer for GSK. My name is Cathy, and I'm your event manager today. (Operator Instructions) I would like to advise all parties, this conference is being recorded for my training purposes. And now I'd like to hand over to David. Please go ahead, sir.
David Simon Redfern - GlaxoSmithKline plc - Chief Strategy Officer
Thanks, Cathy. Good afternoon, everyone. I'm David Redfern, I'm the Chairman of ViiV Healthcare and Chief Strategy Officer for GSK. I'm delighted to welcome you to our Meet the Management Event: Getting Ahead of HIV for analysts and investors. As usual, the presentation materials are available on gsk.com and were sent to people on our distribution list earlier today.
I'd just refer you to Slide 2, which contains our cautionary and forward-looking statements.
Moving on to Slide 3, which provides a summary of what we shall cover today. I'm delighted to be joined by
GlaxoSmithKline PLC Meet GSK Management: Getting Ahead of HIV Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot